Texas Northern Bankruptcy Court

Case number: 8:24-bk-80040 - Eiger BioPharmaceuticals, Inc. - Texas Northern Bankruptcy Court

Case Information
Case title
Eiger BioPharmaceuticals, Inc.
Chapter
11
Judge
Stacey G Jernigan
Filed
04/01/2024
Last Filing
05/03/2024
Asset
Yes
Vol
v
Docket Header

SealedDocument, REFORM, DsclsDue, COMPLEX, jntadmn, LEAD, ClaimsAgent, EXHIBITS




U.S. Bankruptcy Court
Northern District of Texas (Mega Docket DAL)
Bankruptcy Petition #: 24-80040-sgj11

Assigned to: Chief Bankruptcy Jud Stacey G Jernigan
Chapter 11
Voluntary
Asset


Date filed:  04/01/2024
341 meeting:  05/13/2024
Deadline for filing claims:  08/12/2024
Deadline for filing claims (govt.):  09/30/2024

Debtor

Eiger BioPharmaceuticals, Inc.

c/o Douglas Staut, CRO
2100 Ross Avenue
Dallas, TX 75201
SANTA CLARA-CA
Tax ID / EIN: 33-0971591

represented by
Thomas Robert Califano

Sidley Austin LLP
787 Seventh Avenue
New York, NY 10019
212-839-5575
Fax : 212-839-5599
Email: [email protected]

Veronica A. Courtney

Sidley Austin LLP
1000 Louisiana Street
Ste 5900
Houston, TX 77002
713-495-4572
Fax : 713-495-7799
Email: [email protected]

William E Curtin

Sidley Austin LLP
787 Seventh Avenue
New York, NY 10019
212-839-6745
Fax : 212-839-5599
Email: [email protected]

Nathan Elner

Sidley Austin LLP
2021 McKinney Avenue
Suite 2000
Dallas, TX 75201
212-839-5300
Email: [email protected]

John Joseph Kuster

Sidley Austin LLP
787 Seventh Avenue
New York, NY 10019
212-839-7336
Email: [email protected]

Jon Muenz

Sidley Austin LLP
787 7th Avenue
New York, NY 10019
212-839-5901
Fax : 212-839-5599
Email: [email protected]

Patrick J. Neligan, Jr.

Neligan LLP
4851 LBJ Freeway
Suite 700
Dallas, TX 75244
214-912-9861
Email: [email protected]

Charles Martin Persons, Jr.

Sidley Austin LLP
2020 McKinney Avenue, Suite 2000
Dallas, TX 75210
(214) 981-3300
Fax : (214) 981-3400
Email: [email protected]

Anne G. Wallice

Sidley Austin LLP
787 Seventh Avenue
New York, NY 10019
212-839-6021
Email: [email protected]

U.S. Trustee

United States Trustee

1100 Commerce Street
Room 976
Dallas, TX 75202
214-767-8967
represented by
Elizabeth Ziegler Young

U.S. Trustee Office
1100 Commerce Street, Room 976
Dallas, TX 75242
(214) 767-8967
Fax : (214) 767-8971
Email: [email protected]

Latest Dockets
Date Filed#Docket Text
05/03/2024202Docket Text
Application to employ Neligan LLP as Attorney as Conflicts Counsel to the Debtors Filed by Debtor Eiger BioPharmaceuticals, Inc. (Neligan, Patrick)
05/03/2024201Docket Text
Witness and Exhibit List filed by Debtor Eiger BioPharmaceuticals, Inc. (RE: related document(s)[111] Motion to transfer case to District of division. United States Trustees Emergency Motion to Transfer Venue or Dismiss under 28 U.S.C. §§ 1406 and 1408 and Fed. R. Bankr. P. 1014(a)(2), [150] Application to employ Alvarez & Marsal North America, LLC as Other Professional Debtors Application for Entry of an Order Authorizing (I) the Retention of Alvarez & Marsal North America, LLC to Provide the Debtors a Chief Restructuring Officer and C, [154] Motion to establish procedures compensation and expense reimbursement. Debtors' Motion for Entry of an Order Establishing Procedures for Interim Compensation and Reimbursement of Expenses for Retained Professionals, [155] Application to employ Sidley Austin LLP as Attorney Debtors' Application for Entry of an Order Authorizing the Retention and Employment of Sidley Austin LLP as Attorneys for the Debtors and Debtors In Possession Effective as of the Petition Dat). (Attachments: # (1) Exhibit 1 # (2) Exhibit 2 # (3) Exhibit 3 # (4) Exhibit 4 # (5) Exhibit 5 # (6) Exhibit 6 # (7) Exhibit 7 # (8) Exhibit 8) (Califano, Thomas)
05/02/2024200Docket Text
Objection to (related document(s): [111] Motion to transfer case to District of division. United States Trustees Emergency Motion to Transfer Venue or Dismiss under 28 U.S.C. §§ 1406 and 1408 and Fed. R. Bankr. P. 1014(a)(2) filed by U.S. Trustee United States Trustee) Debtors' Objection to United States Trustees Emergency Motion to Transfer Venue Or Dismiss Under 28 U.S.C. §§ 1406 and 1408 and Fed. R. Bankr. P. 1014(A)(2) filed by Debtor Eiger BioPharmaceuticals, Inc.. (Califano, Thomas)
05/02/2024199Docket Text
(1 pg) Order granting motion to appear pro hac vice adding Joseph R. Dunn for Merck Sharp & Dohme LLC (related document # 183) Entered on 5/2/2024. (Rielly, Bill)
05/02/2024198Docket Text
(1 pg) Order granting motion to appear pro hac vice adding Martin E. Beeler for Merck Sharp & Dohme LLC (related document # 182) Entered on 5/2/2024. (Rielly, Bill)
05/02/2024197Docket Text
(1 pg) Order granting motion to appear pro hac vice adding Michael St. Patrick Baxter for Merck Sharp & Dohme LLC (related document # 181) Entered on 5/2/2024. (Rielly, Bill)
05/02/2024196Docket Text
(1 pg) Order granting motion to appear pro hac vice adding Jon Muenz for Eiger BioPharmaceuticals Europe Limited; Eiger BioPharmaceuticals, Inc.; Eiger InnoTherapeutics, Inc.; EigerBio Europe Limited; EB Pharma LLC and EBPI Merger Inc. (related document # 171) Entered on 5/2/2024. (Rielly, Bill)
05/02/2024195Docket Text
(1 pg) Order granting motion to appear pro hac vice adding John Joseph Kuster for Eiger BioPharmaceuticals Europe Limited; Eiger BioPharmaceuticals, Inc.; Eiger InnoTherapeutics, Inc.; EigerBio Europe Limited; EB Pharma LLC and EBPI Merger Inc. (related document # 170) Entered on 5/2/2024. (Rielly, Bill)
05/01/2024194Docket Text
Hearing held on 5/1/2024. (RE: related document(s) 168 Emergency Motion for Entry of Order Authorizing the Debtors to File the Merck Motion, Merck License, and Sublicense Under Seal, filed by Debtor Eiger BioPharmaceuticals, Inc., (Appearances: All Webex. See Appearance List. Nonevidentiary hearing. No opposition to sealing motion. Counsel to upload order.) (Edmond, Michael) (Entered: 05/02/2024)
05/01/2024193Docket Text
Status Conference Hearing held on 5/1/2024. (RE: related document(s) 162 Order (I) Approving the sale of the debtors' Zokinvy assets, (II) Authorizing assumption and assignment of certain executory contracts and unexpired leases related thereto, and (III) Granting related relief (RE: related document(s)94 Order to set hearing), (Appearances: All Webex. See Appearance List. Nonevidentiary status conference. Court heard announcement that Debtor, Merck and Sentynyl are working through issues.) (Edmond, Michael) (Entered: 05/02/2024)